Limited PBS access, shortages may impact add-on therapy


Prevalence of add-on therapy in people with type 2 diabetes is “low” and should be increased to save lives, PBS records analysis finds More Australians with type 2 diabetes need to be offered add-on medications that would better protect them from heart and kidney disease, but shortages and PBS limits have potentially impacted their prescription,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Confusion with Wegovy prescriptions
Next Data breaches hit three-and-a-half-year high